Cx Institutional Biogen Inc. Transaction History

Cx Institutional

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$190.52 - $236.72 $191,472 - $237,903	1,005 New	1,005 $232,000
Q4 2023 Jan 12, 2024	BUY	$222.59 - $267.94 $192,540 - $231,768	865 New	865 $223,000
Q2 2023 Jul 26, 2023	BUY	$275.25 - $318.06 $195,978 - $226,458	712 New	712 $202,000
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $17,441 - $20,740	93 New	93 $19,000
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $71,654 - $92,086	-320 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $4,244 - $5,535	-15 Reduced 4.48%	320 $91,000
Q2 2021 Aug 04, 2021	BUY	$259.0 - $414.71 $25,123 - $40,226	97 Added 40.76%	335 $116,000
Q1 2021 Apr 15, 2021	BUY	$242.95 - $284.63 $7,288 - $8,538	30 Added 14.42%	238 $67,000
Q4 2020 Jan 12, 2021	BUY	$236.26 - $355.63 $14,884 - $22,404	63 Added 43.45%	208 $51,000
Q3 2020 Oct 13, 2020	BUY	$264.77 - $305.71 $20,387 - $23,539	77 Added 113.24%	145 $41,000
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $4,914 - $6,508	-19 Reduced 21.84%	68 $18,000
Q1 2020 Apr 29, 2020	BUY	$268.85 - $341.04 $8,065 - $10,231	30 Added 52.63%	87 $28,000
Q4 2019 Jan 21, 2020	BUY	$220.06 - $304.07 $7,922 - $10,946	36 Added 171.43%	57 $17,000
Q3 2019 Oct 10, 2019	SELL	$217.44 - $243.88 $6,958 - $7,804	-32 Reduced 60.38%	21 $5,000
Q2 2019 Jul 17, 2019	BUY	$219.29 - $241.72 $219 - $241	1 Added 1.92%	53 $12,000
Q1 2019 Apr 03, 2019	BUY	$216.71 - $338.96 $11,268 - $17,625	52 New	52 $12,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.